• OPEN AN ACCOUNT
Indian Indices
Nifty
26,202.95 -12.60
(-0.05%)
Sensex
85,706.67 -13.71
( -0.02%)
Bank Nifty
59,752.70 15.40
( 0.03%)
Nifty IT
37,405.50 -40.80
( -0.11%)
Global Indices
Nasdaq
47,737.43 289.30
(0.61%)
Dow Jones
6,869.48 35.87
(0.52%)
Hang Seng
50,220.95 53.85
(0.11%)
Nikkei 225
9,721.02 27.09
(0.28%)
Forex
USD-INR
89.30 0.10
(0.11%)
EUR-INR
103.54 0.22
(0.21%)
GBP-INR
118.23 0.49
(0.41%)
JPY-INR
0.57 0.00
(0.17%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
41.17
813.1
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.22
 

madhucon projects ltd
Ind-Agiv Commerce reports standalone net loss of Rs 0.29 crore in the September 2025 quarter
Nov 17,2025
Net Loss of Ind-Agiv Commerce reported to Rs 0.29 crore in the quarter ended September 2025 as against net loss of Rs 0.64 crore during the previous quarter ended September 2024. Sales declined 64.36% to Rs 0.36 crore in the quarter ended September 2025 as against Rs 1.01 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales0.361.01 -64
OPM %-127.78-17.82 -
PBDT-0.29-0.64 55
PBT-0.29-0.64 55
NP-0.29-0.64 55